King Hussein Cancer Center

Reports that name this provider

Advanced Imaging Quality in Jordan

PET/CT and SPECT/CT programs with on-site Ga68 radiotracer synthesis, IAEA Collaborating Centre and EANM/EARL Centre of Excellence, 13,140+ procedures annually (2022), JCI-accredited, serves one-third of 7,000 annual new patients from outside Jordan, coordinates care with MD Anderson Cancer Center and St. Jude Children's Research Hospital

Assisted Dying Foreigner Access in Jordan

First JCI-accredited cancer center in the developing world

Assisted Dying Organizations in Jordan

Established its first palliative care unit in 2004. Provides inpatient, outpatient, and home-based palliative services. As of 2026, remains the principal palliative care institution in the country. Expanded services through a Ministry of Health agreement to underserved eastern regions. Palliative medicine received formal subspecialty recognition from the Jordanian Medical Council in 2017 with a two-year fellowship program accredited in 2018.

Assisted Dying Process in Jordan

Breast Surgery Quality in Jordan

First specialized cancer center in the developing world to achieve JCI disease-specific certification; houses the oncoplastic reconstruction unit led by Dr. Khaldoun Haddadin

Cancer Screening Quality in Jordan

First JCI-accredited disease-specific cancer center in developing world. Holds JCI General Accreditation, JCI Clinical Care Program Certification (CCPC) for cancer care, HCAC accreditation for Breast Imaging Unit, CAP laboratory accreditation, Arab Board-approved training center for mammography (first in Arab world), ANCC Magnet nursing recognition. Early Detection Unit offers mammography, colonoscopy, Pap smears, fecal occult blood testing, prostate screening. Treated 35,000 patients in 2024. International Patients Office provides interpretation services, accommodation support, unified pricing for all nationalities.

Cancer Treatment Cost Savings in Jordan

JCI Clinical Care Program Certification for cancer; partnerships with MD Anderson Cancer Center and St. Jude Children's Research Hospital; processes 250+ bone marrow transplants annually with success rates over 85%; treats approximately 7,000 new patients annually and over 14,000 admissions; operates Cancer Care Insurance (CCI) program open to all ages and nationalities

Cardiac Diagnostics in Jordan

First institution in the region accredited by the European Association of Nuclear Medicine (EANM) for PET/CT quality (EARL accreditation). Operates PET/CT and SPECT/CT equipment.

Chemotherapy & Immunotherapy Quality in Jordan

352-bed standalone cancer center handling 60% of Jordan's cancer cases. 434 oncologists and consultants, 1,360+ oncology nurses, 140 qualified pharmacists. Delivered 45,000 chemotherapy sessions in 2019 with 250,000 outpatient visits annually. JCI-accredited disease-specific cancer center (first in developing world, sixth globally), MAGNET nursing accreditation, CAP accreditation, AHRPP certification, and IAEA collaborating centre. Three-year Medical Oncology Fellowship program accredited by Jordanian Medical Council; fellows ranked first in 2019 ASCO in-training examination. Approximately 250 blood and bone marrow transplants annually with 85%+ success rate. Hospital-based Health Technology Assessment program established 2013 has approved 70%+ of novel cancer drugs requested after price negotiations. Treats thousands of international patients annually with dedicated Office of International Patient Affairs. Treatment costs 25-40% below US/Europe. Telemedicine support and multilingual document translation (Arabic, English, French, Kurdish).

Dental Surgery Quality in Jordan

JCI accreditation as hospital (since 2006) and disease-specific cancer center (since 2007). First disease-specific cancer center in developing world and only sixth worldwide. Performs over 5,000 surgeries annually with dedicated Head and Neck Program.

Diagnostic Accreditation in Jordan

First facility in Jordan and fifth in Arab world to earn CAP accreditation (2009), holds JCI CCPC

Diagnostic Turnaround in Jordan

Holds College of American Pathologists (CAP) accreditation for laboratories - first hospital in Jordan and fifth in Arab world with this accreditation. Provides comprehensive oncologic pathology with specialized staining and interpretation.

End-of-Life Cost in Jordan

Jordan's only comprehensive inpatient palliative care unit. Provides home care service with supervised visits, medications, and medical supplies at patient residence. Offers medical device lending program including oxygen concentrators and hospital beds. KHCC Goodwill Fund covers treatment, accommodation, transport, and meals for underprivileged patients.

Genetic Testing Availability in Jordan

CAP accreditation; first hospital in Jordan to achieve CAP; maintains Office of International Patient Affairs; accepts international patient applications via WhatsApp and email with unified price list for all nationalities

Hospital Accreditation in Jordan

JCI Disease-Specific Certification as first cancer center in developing world and sixth worldwide; College of American Pathology (CAP) laboratory accreditation; partnerships with MD Anderson Cancer Center and St. Jude Children's Research Hospital; maintains dedicated international patient office

Hydrotherapy Facilities in Jordan

JCI disease-specific accreditation (first such center in the developing world). Conducts more than 25,000 treatment sessions annually across all modalities. Hydrotherapy for oncology rehabilitation and lymphedema treatment.

Hyperthermia Treatment in Jordan

JCI disease-specific cancer center accreditation, 352 inpatient beds, 13 operating rooms, 36 ICU beds, treats 4,000–5,000 new patients annually, employs 434 oncologists and consultants, over 1,360 oncology nurses, 140 pharmacists, 1,500 technicians and health care specialists

Integrative Medicine Quality in Jordan

First in the developing world to earn JCI disease-specific cancer accreditation; studied CAM use among patients but does not operate formal integrative oncology program

Integrative Oncology Quality in Jordan

Jordan's sole dedicated comprehensive cancer hospital treating 3,500 new cancer patients annually (approximately 70% of country's cancer caseload). Holds JCI disease-specific cancer certification (first in developing world), CAP laboratory accreditation (first in Jordan), Magnet Recognition (first specialized cancer center outside US), and eight additional quality certifications. AAHRPP international clinical research accreditation. Employs interdisciplinary team including psychologists, counselors, social workers, child life specialists, spiritual care providers, and nine dietitians/nutrition professionals. International Patients' Office provides translation services (English, French, Kurdish) and medical transport coordination. Strategic partnerships with MD Anderson Cancer Center and St. Jude Children's Research Hospital. Treatment costs 25–40% lower than US and Europe.

Ketamine Therapy Availability in Jordan

JCI-accredited

Medical Technology in Jordan

IAEA Collaborating Centre; CAP-certified laboratory; introduced first robotic surgical system in January 2022; new radiation oncology building opened July 2024; performs approximately 80 bone marrow/stem cell transplants annually

Medication Availability in Jordan

352-bed JCI-accredited institution, introduced pembrolizumab in 2017, treated 244 advanced-stage NSCLC patients with immunotherapy (2017-2022), operates Hospital-Based Health Technology Assessment Program, first institution in developing world to receive JCI disease-specific cancer accreditation, 7,000 new patients annually

Medication Cost Savings in Jordan

First JCI-accredited disease-specific cancer center in the developing world. Implements Hospital-Based Health Technology Assessment (HTA) program to evaluate and introduce cancer therapeutics including immunotherapies and targeted biologics.

Neurosurgery Quality in Jordan

JCI disease-specific cancer center accreditation. 13 state-of-the-art operating rooms including dedicated Brain Suite with integrated intraoperative MRI enabling real-time tumor assessment mid-procedure. First institution in Middle East to perform brain tumor surgery combining laser interstitial thermal therapy, robotic guidance, and intraoperative MRI. Introduced robotic surgery to Jordan in January 2022. Performs more than 5,000 surgeries annually. Internationally recognized residency and fellowship programs in surgical oncology accredited by European Society of Oncological Surgery. MAGNET nursing excellence award. Published outcomes (2,094 patients, 2003-2019): meningioma 5-year overall survival 84%; pediatric circumscribed astrocytic glioma 5-year OS 92%; medulloblastoma 5-year OS 67%.

Oncologic Surgery Quality in Jordan

352-bed, 108,700 m² non-governmental not-for-profit comprehensive cancer center treating approximately 60% of Jordan's cancer burden; 5,000+ major cancer surgeries annually; 400+ oncology doctors; 13 operating rooms with specialized Brain Suite equipped with intraoperative MRI; JCI disease-specific cancer certification (first cancer center outside US), OECI membership, CAP laboratory accreditation, Magnet nursing recognition, AAHRPP research accreditation; first and only robotic cancer surgery program in Jordan; NanoKnife technology; fellowship programs accredited by Jordanian Medical Council and Arab Board; 109 residents and 38 fellows in training

Palliative Care Quality in Jordan

JCI-accredited cancer center; operates inpatient palliative unit, outpatient clinics, and home care program; first institution in developing world to earn JCI disease-specific cancer accreditation; palliative medicine fellowship program accredited 2018; functions as regional training hub

Palliative Sedation Availability in Jordan

JCI-accredited tertiary cancer center with Department of Palliative Medicine offering inpatient unit, outpatient clinics, home care services, and medical equipment lending. Staffed with American Board-Certified palliative medicine physicians, nurses, pharmacists, social worker, and chaplain. Serves approximately 60% of Jordan's cancer burden. International Patient Affairs Office provides interpretation services in English, French, and Kurdish. Institutional ethics committee. 2012 service volumes: 400 inpatient consultations, 979 referrals/admissions, 1,133 outpatient visits, 1,501 home care visits. Training center for nursing and medical residents.

Pathology Quality in Jordan

CAP accredited since 2009 (first in Jordan, fifth in Arab world). Processes over 8 million tests annually with mandatory histology review. Weekly multidisciplinary tumor board. ISO-compliant cancer biobank established 2011. Six specialized laboratories with full laboratory automation, MALDI-TOF mass spectrometry, molecular NAATs, advanced immunohistochemistry. Provides consultation services.

Preventive Screening Packages in Jordan

Only comprehensive cancer center in Jordan, one of only six JCI-accredited disease-specific cancer centers worldwide, performs over 13,140 nuclear medicine procedures annually, first JCI-accredited disease-specific cancer center outside developed world, offers F18-FDG PET/CT, Ga68-DOTATOC PET/CT for neuroendocrine tumors, Ga68-PSMA PET/CT for prostate cancer, DEXA bone densitometry, and colonoscopy screening services

Psilocybin Treatment Legality in Jordan

Internationally accredited hospital

Radiation Therapy Quality in Jordan

Operates 6 ultra-modern LINACs with X-ray tracking/IGRT; JCI accreditation (February 2006, first in Jordan); JCI Disease-Specific Cancer Certification in Oncology (first cancer center outside US to achieve this); College of American Pathologists laboratory accreditation; ANCC Magnet nursing certification (first specialized cancer center outside US with this designation); IAEA Collaborating Centre; IAEA Rays of Hope Anchor Centre (designated September 2023); new Radiation Oncology building opened July 2024 (2,700 m²), expanded monthly capacity from 260 to 400 patients; treats over 7,000 new cancer patients annually (~60% requiring radiotherapy); has served over 70,000 patients from Jordan and Arab world over 25 years; employs 17 radiation oncologists, 13 residents; telemedicine/telesynergy capabilities; international partnerships with MD Anderson, St. Jude Children's Hospital, National Cancer Institute, Princess Margaret Cancer Centre, Moffitt Cancer Center; operates largest bone marrow transplant program in Middle East (250 transplants in 2022, success rates exceeding 85%); pediatric cancer program treats ~90% of Jordan's pediatric cancer patients; second site in Aqaba; medically trained staff including radiation oncology residents with US/UK externships; virtual reality brachytherapy training program

Second Opinion Services in Jordan

Only Jordanian center with mandatory multidisciplinary tumor board; operates Multi-Modality Clinics (MMCs) meeting weekly with medical oncologist, surgical oncologist, radiation oncologist; JCI accredited since 2006 (first in Jordan); JCI Clinical Care Program Certification for cancer (first center outside US); College of American Pathologists laboratory accreditation (first in Jordan, fifth in Arab world); ANCC Magnet Recognition (first specialized cancer center outside US); AAHRPP accreditation (eighth worldwide); uses TeleSynergy technology for real-time international case consultations with MD Anderson and Princess Margaret Hospital; Office of International Patient Affairs coordinates case submission

Specialist Credentials in Jordan

JMC- and Arab Board-accredited fellowship programs; ranked at top of all North American fellowship programs in 2019 ASCO in-training examination; first cancer center in developing world and sixth worldwide to receive JCI disease-specific cancer center accreditation; over 100 oncologists graduated from programs; sponsors subspecialty training at Princess Margaret Hospital (Toronto), MD Anderson Cancer Center, and Leeds Cancer Centre

Stem Cell Legality in Jordan

Established BMT program in 2003; performs approximately 200 transplants annually, expanded to 300 in 2024; over 1,546 adult transplants since 2003; JCI accredited; EBMT membership; 24 dedicated inpatient beds with HEPA filtration; treated 35,000 patients in 2024; established first public umbilical cord stem cell bank

Stem Cell Therapy Quality in Jordan

JCI accreditation, CAP-certified laboratories, Flow Cytometry lab is only CAP-accredited in Jordan, Cell Therapy and Applied Genomics Department, aspirations for FACT, ASHI, and JACIE accreditations

Stem Cell Transplant Quality in Jordan

Adult BMT program founded 2003; performs approximately 200 transplants annually; FACT-JACIE, JCI, and CAP accreditation; completed over 1,546 adult procedures since inception; 70% five-year survival (2003-2009); 85%+ success rate (2022, 250 transplants); 24-bed inpatient ward with 15 HEPA-filtered isolation rooms; operates Jordan's first public umbilical cord blood bank; dedicated Office of International Patient Affairs; international partnerships with MD Anderson Cancer Center, St. Jude's Children's Hospital, and National Cancer Institute

Telemedicine Diagnostics in Jordan

JCI-accredited disease-specific cancer center, first JCI-certified cancer center in the developing world, offers internationally accessible oncology teleconsultations via Tebcan partnership, has international patient department coordinating pre-travel consultations and post-discharge telemedicine follow-up